The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

imagen.ai

Total Raised

$109.32M

Investors Count

7

Deal Terms

1

Imagen Technologies Funding, Imagen Technologies Valuation & Imagen Technologies Revenue

5 Fundings

Imagen Technologies's latest funding round was a Series C for $50M on February 1, 2021.

Imagen Technologies's valuation in March 2017 was $44.8M.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/1/2021

Series C

$50M

Undisclosed Investors

0

FY undefined

9/1/2018

Series B

$99M

0

FY undefined

0

3/15/2017

Series A

$99M

$44.8M

0

FY undefined

10

6/22/2016

Seed VC

$99M

0

FY undefined

10

Other Investors

0

FY undefined

0

Date

2/1/2021

9/1/2018

3/15/2017

6/22/2016

Round

Series C

Series B

Series A

Seed VC

Other Investors

Amount

$50M

$99M

$99M

$99M

Investors

Undisclosed Investors

Valuation

$44.8M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

0

10

10

0

Imagen Technologies Deal Terms

1 Deal Term

Imagen Technologies's deal structure is available for 1 funding round, including their Series A from March 15, 2017.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Imagen Technologies Investors

7 Investors

Imagen Technologies has 7 investors. HSS Global Innovation Fund invested in Imagen Technologies's Series A funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/22/2016

3/15/2017

2
Seed VC, Series A (2017)

Corporate Venture

New York

00/00/0000

00/00/0000

Threshold Ventures

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Nexus Venture Partners

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Zach Weinberg

Subscribe to see more

Angel Investor (Individual)

New York

Google Ventures

Subscribe to see more

Corporate Venture

California

First funding

6/22/2016

00/00/0000

00/00/0000

00/00/0000

Last Funding

3/15/2017

00/00/0000

00/00/0000

00/00/0000

Investor

Threshold Ventures

Nexus Venture Partners

Zach Weinberg

Google Ventures

Rounds

2
Seed VC, Series A (2017)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Corporate Venture

Venture Capital

Venture Capital

Angel Investor (Individual)

Corporate Venture

Location

New York

California

California

New York

California

You May Also Like

QUIBIM Logo
QUIBIM

Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.

R
RadNet

RadNet is a national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. The company has a network of 293 owned and/or operated outpatient imaging centers.

A
Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.

PathAI Logo
PathAI

PathAI provides AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.

P
Paige

Paige delivers AI-powered digital diagnostics and biomarkers for pathologists, oncologists, and the R&D community worldwide, while also working closely with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The firm's target customers include pathologists, hospital leads/chairs as well as life sciences research and translational teams.

Viz.ai Logo
Viz.ai

Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.